One third of hepatitis B carriers in Hong Kong have severe liver fibrosisBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39556.489097.DB (Published 24 April 2008) Cite this as: BMJ 2008;336:909
- Jane Parry
- 1Hong Kong
Researchers in Hong Kong have found that one third of people in the city who are hepatitis B carriers have severe fibrosis, including almost a fifth of patients with normal alanine transferase (ALT) concentrations. The findings of a study of 1315 hepatitis B carriers were published in the American Journal of Gastroenterology (2008 Apr 16; doi: 10.1111/j.1572-0241.2007.01751.x).
“It’s known that severe fibrosis and cirrhosis can lead to complications, including liver cancer, but we didn’t know the extent of the problem of severe fibrosis,” said Man-fung Yuen, coauthor of the study and associate professor at the University of Hong Kong’s department of medicine.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial